Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Covance Laboratories Inc.
EIR
•Covance Laboratories Inc.•June 6, 2014

Covance Laboratories Inc. – FDA EIR, Jun 6, 2014

Record Details

An FDA inspection of Covance Laboratories, Inc. in Chantilly, VA, was conducted from June 3-6, 2014. The inspection was a high-priority pre-approval data validation audit focused on bioequivalence and pharmacokinetics/pharmacodynamics studies for human drugs, operating under the regulatory framework of 21 CFR 320.29(a) and BioAnalytical Method Validation guidance. The inspection reviewed various records, including sample management, equipment calibration, and personnel training, for specific bioanalytical projects.

Crucially, the inspection concluded without the issuance of an FDA Form 483, signifying that no objectionable conditions requiring formal corrective action were identified. Discussions with management included minor observations, such as instances of incorrect outlier flagging in data tables (which did not affect study results), and questions regarding matrix effects in calibrator and quality control sample preparation. Some internal procedural deviations were noted in study correspondence, such as minor centrifugation time discrepancies and data saving issues due to network problems, but these were deemed by the firm's Principal Investigator to have no impact on study integrity. No formal violations were cited, and no required actions or voluntary corrections were mandated as a result of this inspection.

Company
Covance Laboratories Inc.
Inspection date
June 6, 2014
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Sam Haidar (Senior Advisor, Office of Study Integrity and Surveillance)
  • Michael F. Skelly (issuing_officer)
  • John Dan (investigator)
View Company Profile

ID · abc6b0ee-c69e-417c-9821-15d3d3a0694f

Violation Codes2
21 CFR 31221 CFR 320.29(a)

Full citation text and observation details available on the Dashboard.

Other documents for Covance Laboratories Inc.
  • EIR - 2020-02-14February 14, 2020
  • 483 - 2018-08-17August 17, 2018
  • EIR - 2017-07-26July 26, 2017
  • EIR - 2016-01-20January 20, 2016
  • EIR - 2010-08-19August 19, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Covance Laboratories Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.